Modified 2' And 3'-Nucleoside Prodrugs For Treating Flaviridae Infections

Patent No. EP2332952 (titled "Modified 2' And 3'-Nucleoside Prodrugs For Treating Flaviridae Infections") was filed by Centre National DE LA Recherche Scientifique Cnrs on Jun 27, 2003. The application was issued on Apr 29, 2015.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKJan 29, 2016FRKELLY
GILEAD SCIENCESJan 28, 2016NIEUWENHUYS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2332952

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Application Number
EP10183144A
Filing Date
Jun 27, 2003
Status
Revoked
Mar 25, 2022
Publication Date
Apr 29, 2015